Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
71 participants
INTERVENTIONAL
2016-05-31
2017-11-03
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Pilot Study of cNEP for the Treatment of Snoring
NCT02767843
Continuous Negative External Pressure for the Treatment of Primary Snoring
NCT03372070
Variable Negative External Pressure (vNEP) - An Alternative to Continuous Positive Airway Pressure (CPAP) for the Treatment of Obstructive Sleep Apnea (OSA): A Pilot Study
NCT04718142
Effectiveness and Safety of cNEP in Ethnic Japanese With Obstructive Sleep Apnea
NCT03375905
A Post-marketing Surveillance of the Negative Pressure Sleep Therapy System to Treat Obstructive Sleep Apnea
NCT02698059
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
cNEP
Subjects with OSA will be treated with cNEP (continuous negative external pressure) at home for three weeks
cNEP
continuous negative external pressure
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
cNEP
continuous negative external pressure
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* on that PSG, AHI must be 10 - 50/hr and \>80% of the apneas and hypopneas must be obstructive
* no significant changes in health, medications, or lifestyle since the qualifying PSG
Exclusion Criteria
* beard or excessive hair on the area of the neck where the collar will be applied
* carotid artery disease
* serious medical conditions
* pregnancy
* use of home oxygen
* silicone allergy
* sleep disturbance other than obstructive sleep apnea
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Sommetrics, Inc.
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Adam Blackman, MD
Role: PRINCIPAL_INVESTIGATOR
Toronto Sleep Institute
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Toronto Sleep Institute
Toronto, Ontario, Canada
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
SOM-015
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.